Fortas, Camille
Harimanana, Aina Nirina
Rasoanandrianina, Solange Bienvenue
Rasoanaivo, Tsinjo Fehizoro
Razanadranaivo, Hobisoa Léa
Mangahasimbola, Reziky Tiandraza
Rasolon, Dimitri Toky
Rafetrarivony, Lala Fanomezantsoa
Rasolofomanana, Tsiry Tahina
Rabarisoa, Laurah
Huynh, Bich-Tram
Randremanana, Rindra Vatosoa
Crucitti, Tania
Funding for this research was provided by:
European and Developing Countries Clinical Trials 2 - EDCTP2 (RIA2020I-3297, RIA2020I-3297, RIA2020I-3297, RIA2020I-3297, RIA2020I-3297, RIA2020I-3297, RIA2020I-3297, RIA2020I-3297, RIA2020I-3297, RIA2020I-3297, RIA2020I-3297, RIA2020I-3297)
Article History
Received: 14 February 2024
Accepted: 30 January 2025
First Online: 24 February 2025
Declarations
:
: The ethical committee (Comité d’Ethique de la Recherche Biomédicale, CERBM) in Madagascar approved the study protocol (N° 124-MSANP/SG/AMM/CERBM). All participants gave their informed consent prior to joining the study.
: Not applicable.
: This work was, in part, presented at the STI & HIV 2023 world congress.
: The authors declare no competing interests.